10th Edition of
World Congress on Infectious Diseases & One Health
October 05-07, 2026 | Tokyo, Japan
Antimicrobial Drug Resistance poses a growing threat to global health, challenging our ability to treat bacterial, viral, and fungal infections effectively. The overuse and misuse of antimicrobial drugs contribute significantly to the development of resistance, rendering once-potent medications less effective. This complex issue arises from factors such as improper prescription practices, patient non-compliance, and the widespread use of antibiotics in agriculture. The emergence of multidrug-resistant strains heightens the urgency of addressing this crisis. Resistant infections lead to prolonged illness, increased healthcare costs, and higher mortality rates. The need for innovative research and development of new antimicrobial agents becomes paramount to stay ahead of evolving resistance mechanisms.
Title : Molecular crosstalk between the host and pathogen in Streptococcus pyogenes virulence
Francis J Castellino, University of Notre Dame, United States
Title : Phenotypic characterisation of non tuberculous mycobacterium species isolated from clinical specimens
Anant Marathe, Parul Institute of Medical Sciences and Research, Parul University, India
Title : An unprecedented West Nile virus outbreak in Israel (2024): A textbook case for the One Health approach
Michel Bellaiche, Kimron Veterinary Institute, Israel
Title : Changing population immunity to COVID-19 in the context of infection, vaccination and emerging SARS-CoV-2 variants
Ranjan Ramasamy, IDFISH Technology, United States
Title : Candida auris infections are global health challenge
Reza Nassiri, Michigan State University, United States
Title : Host brakes on viral inflammation
Saurabh Chattopadhyay, University of Kentucky College of Medicine, United States